Catherine M. Szyman - 31 May 2023 Form 4 Insider Report for Outset Medical, Inc. (OM)

Reporting relationship: Director
Issuer ticker: OM
Reported as of: 31 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 31 May 2023, 19:10:24 UTC
Prior SEC filing: 19 May 2023
Next SEC filing: 13 Jun 2023
Source filing: View source filing
Reporting owner signature: By: John L Brottem For: Catherine M Szyman

Key filing fact

Catherine M. Szyman filed Form 4 for Outset Medical, Inc. (OM) on 31 May 2023.

Key facts

This page summarizes Catherine M. Szyman's Form 4 filing for Outset Medical, Inc. (OM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 31 May 2023, 19:10.

Change

Previous filing in this sequence was filed on 19 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OM transaction

Common Stock

Award

Transaction value: $0
Shares: +7,681
Change %: +45%
Price: $0.000000
Shares after: 24,596
Date: 31 May 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders